Pharmaceutical SOPs: GMP Compliance, Templates & AI Generator
Generate GMP-compliant procedures for drug manufacturing, quality assurance, laboratory testing, and pharmaceutical regulatory compliance.
Pharmaceutical manufacturing operates under one of the world's strictest regulatory regimes. 21 CFR Part 211 (US cGMP) prescribes written procedures for production, quality control, packaging, distribution, and complaint handling. EU GMP adds Annex 1 (sterile manufacturing), Annex 11 (computerized systems), and Part II (active pharmaceutical ingredients via ICH Q7). FDA Warning Letters and EMA inspection findings consistently identify the same root cause: SOPs that are missing, outdated, or not followed in practice. Data integrity — ALCOA+ — is now scrutinized in every inspection. WorkProcedures generates pharmaceutical SOPs grounded in real industry procedures across drug substance, drug product, biologics, and combination products, with terminology and structure that matches what FDA, EMA, MHRA, and PMDA inspectors expect to read.
Pharmaceutical regulations & compliance context
Every pharmaceutical SOP WorkProcedures generates is grounded in these frameworks. Know what your SOPs need to cover before an auditor arrives.
21 CFR Part 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals
The US FDA's cornerstone GMP regulation. Requires written procedures for personnel, facilities, equipment, components, production, packaging, laboratory controls, records, and complaints. Each subpart specifies SOP content — e.g. §211.100 requires written production procedures including a description of the drug product, formula, identification of equipment, and detailed manufacturing instructions.
EU GMP Volume 4 — Including Annex 1 (Sterile) and Annex 11 (Computerized Systems)
The EU's equivalent to US cGMP. Annex 1 (revised 2022, in force 2023) imposes Contamination Control Strategy requirements on sterile manufacturing — a substantial uplift requiring new SOPs on environmental monitoring, gowning qualification, isolator interventions, and visual inspection. Annex 11 governs computerized systems including audit trails, electronic signatures, and validation lifecycle.
ICH Q7 — GMP Guide for Active Pharmaceutical Ingredients
Global standard for API and intermediate manufacturing. Covers process equipment, validation, change control, complaints, and contract manufacturers. Both FDA and EMA inspect against ICH Q7 for API operations. Companies producing both APIs and finished dosage forms need SOPs aligned with both Q7 and Part 211.
21 CFR Part 11 — Electronic Records & Electronic Signatures
Applies whenever pharmaceutical records are created, modified, maintained, or transmitted electronically. Requires validated systems, audit trails of all data changes, secure user access controls, and electronic signatures with linked meaning (signature manifests). FDA 483 findings on Part 11 have surged since 2018; SOPs must specifically address Part 11 controls.
ICH Q9 / Q10 — Quality Risk Management & Pharmaceutical Quality System
ICH Q9 formalizes risk-based decision-making (FMEA, HACCP, fault-tree analysis) for product quality decisions. ICH Q10 defines the modern Pharmaceutical Quality System (PQS) integrating GMP with product lifecycle management. Inspectors increasingly expect SOPs to reference Q9 risk tools and Q10 PQS elements like Management Review and CAPA effectiveness.
ALCOA+ Data Integrity Principles (FDA, MHRA, EMA, PMDA)
Data must be Attributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring, and Available. SOPs must explicitly embed ALCOA+ practices: signing batch records as work is performed (not at end of shift), preserving original raw data (not transcribed summaries), and documenting all corrections with the original entry still legible. ALCOA+ findings now dominate FDA Warning Letters.
20+ pharmaceutical SOPs you can generate today
Every procedure below can be generated in under 2 minutes at Standard, Comprehensive, or audit-ready Enterprise tier.
Batch Record Review and Approval (21 CFR 211.192)
Quality Unit review of executed batch records before release. 100% review of critical-step entries (weight, in-process tests, deviations), exception review for non-critical steps. Reviewer qualifications, rejection criteria, and signature requirements.
Environmental Monitoring SOP (Cleanroom)
Viable and non-viable particle sampling per Annex 1 grade (A/B/C/D or ISO 5/7/8). Sample location selection, frequency, alert/action limits, excursion investigation, and trending against control charts.
Aseptic Gowning Qualification (Annex 1)
Initial gowning qualification (typically 3 successful gownings with environmental monitoring), requalification frequency, gowning sequence with critical-zone protection, and gown failure investigation protocol.
Deviation Investigation & Root Cause Analysis
Deviation classification (minor/major/critical), 30-day investigation closure, 5 Whys or Fishbone root cause analysis, impact assessment on the batch and adjacent batches, and CAPA development with effectiveness verification.
CAPA (Corrective and Preventive Action) Procedure
CAPA initiation triggers, root cause analysis methodology, action plan with assigned owners and due dates, effectiveness verification (typically 90 days post-implementation), and CAPA effectiveness trending for the Management Review.
Cleaning Validation Protocol & Report
Cleaning agent selection, worst-case product identification, equipment train sampling locations, residue limit calculation (0.1% therapeutic dose or 10ppm criterion), recovery studies, and three-consecutive-successful-runs requirement.
Equipment Qualification — IQ/OQ/PQ
Installation Qualification (built per spec, calibrations current), Operational Qualification (operates across ranges), Performance Qualification (delivers product specifications consistently). Each stage protocol, execution, and approval before progression.
Computer System Validation (CSV) — Annex 11 / Part 11
User Requirements Specification, Functional Specification, design qualification, IQ/OQ/PQ for the system, electronic record / electronic signature controls, audit trail review, periodic review (typically annual), and change control.
Annual Product Review (APR / PQR)
Annual review of batches manufactured, including yield, deviations, CAPAs, complaints, returns, and out-of-specification results. Trending and statistical analysis to identify drift requiring action.
Stability Study Protocol & Report
ICH Q1A stability conditions (long-term, intermediate, accelerated), pull schedule, testing methods, specifications, and OOS handling. Used to establish shelf life and storage conditions.
Raw Material Sampling, Testing & Release
ANSI/ASQ Z1.4 sampling plans, identity test on every container (or skip-lot per cGMP §211.84), full analytical testing, vendor qualification status verification, and quarantine until release.
Out-of-Specification (OOS) Investigation
Phase I (laboratory investigation — analyst error, instrument fault), Phase II (manufacturing investigation if Phase I doesn't identify cause), retest justification, and final disposition decision. Required closure timeframe typically 30 days.
Change Control Procedure
Change classification (like-for-like vs. impacting product / process / system), impact assessment, regulatory reporting decision (annual report, CBE-30, prior approval), implementation, and effectiveness review.
Supplier / Vendor Qualification
Vendor questionnaire, on-site audit (for critical suppliers), quality agreement, sample testing, and ongoing performance monitoring. Required for raw materials, components, contract manufacturers, and testing laboratories.
Master Production and Control Records (MPCR)
Per 21 CFR 211.186: drug product name and strength, formula, master formula sheet, complete manufacturing and control instructions, sampling and testing procedures, and specifications. The 'recipe' batch records are executed against.
Complaint Handling & Adverse Event Reporting
Complaint receipt logging, classification (product quality vs. adverse event), investigation, root cause and CAPA, regulatory reporting (15-day MedWatch, 7-day expedited reports for ICSRs), and trending.
Recall Procedure
Recall classification (Class I/II/III), regulatory notification (FDA within 24-72 hours depending on class), customer notification, product retrieval, effectiveness check (typically 95%+ of distributed lots accounted for), and final disposition.
Personnel Training & Qualification
Initial training (GMP fundamentals, hazcom, role-specific SOPs), training effectiveness verification, requalification frequency (typically annual for critical roles), and training records retention.
Document Control & Retention
SOP issuance, controlled copies (numbered, watermarked), revision control, retirement of obsolete SOPs, training on changes, and retention per regulatory requirement (typically 1 year past expiration for batch records).
Internal Audit Program
Annual internal audit plan covering all GMP areas, audit team independence from audited areas, finding classification, CAPA tracking, and Management Review reporting.
Pharmaceutical procedure use cases
Generate SOPs for a wide range of pharmaceutical requirements:
Why use WorkProcedures for pharmaceutical?
GMP compliance
Procedures aligned with FDA 21 CFR Parts 210/211 and EU GMP Annex requirements.
Audit readiness
Inspection-ready documentation for FDA, EMA, and client audits.
Data integrity
Procedures supporting ALCOA+ principles for complete, accurate data documentation.
Example pharmaceutical SOP
Here's a real example of the type of SOP you can generate for pharmaceutical:
More pharmaceutical SOPs you can generate:
How to generate pharmaceutical SOPs
Describe your requirement
Enter a plain-English description of the pharmaceutical procedure you need.
AI generates your SOP
Our AI searches 10,000+ industry procedures and generates a tailored pharmaceutical SOP with numbered steps and best practices.
Review, edit, and publish
Review the generated procedure, make any edits, and export as PDF or Word to share with your team.
Other industries
WorkProcedures supports SOPs across 35 industries.